Breaking News Instant updates and real-time market news.

DPLO

Diplomat Pharmacy

$20.16

0.02 (0.10%)

13:21
04/06/18
04/06
13:21
04/06/18
13:21

Diplomat Pharmacy files automatic common stock offering

  • 16

    Apr

  • 12

    Jun

DPLO Diplomat Pharmacy
$20.16

0.02 (0.10%)

03/08/18
LEHM
03/08/18
INITIATION
Target $27
LEHM
Overweight
Diplomat Pharmacy initiated with an Overweight at Barclays
Barclays analyst Steve Valiquette started Diplomat Pharmacy with an Overweight rating and $27 price target. The analyst initiated 14 companies in Health Care Services with a Neutral industry view.
03/12/18
LEER
03/12/18
NO CHANGE
LEER
Diplomat Pharmacy may be next takeover target, says Leerink
Leerink analyst David Larsen believes Diplomat Pharmacy (DPLO) could be the next takeover target following last week's buyout of Express Scripts (ESRX). A managed care plan or large pharmacy chain may find Diplomat's portfolio compelling, Larsen told investors earlier in a research note. He believes the rally post Cigna's (CI) acquisition of Express Scripts reflects a higher likelihood of a takeover, but that "significant upside" potential remains in Diplomat shares.
03/29/18
LSCM
03/29/18
NO CHANGE
Target $35
LSCM
Buy
Diplomat misperception creating 'exceptional opportunity,' says Lake Street
Lake Street analyst Brooks O'Neil noted that drug price inflation is currently a popular "hot button" and healthcare "middlemen" are being pointed to as the key problem in the cost escalation. However, he sees Diplomat Pharmacy as a unique and attractive part of the solution, not part of the problem, and he believes the current misperception of the company and its business presents an "exceptional opportunity for investors." O'Neil affirmed his Buy rating and $35 price target on Diplomat shares.
04/06/18
LSCM
04/06/18
NO CHANGE
Target $35
LSCM
Buy
Diplomat well positioned amidst industry consolidation, says Lake Street
Lake Street analyst Brooks O'Neil says Diplomat Pharmacy is well positioned as pending mergers bring changes to the healthcare marketplace. The company's PBM/Specialty Pharmacy/Home Infusion businesses are "strategically and financially attractive" and pending consolidation creates "attractive scarcity," which will benefit Diplomat materially, O'Neil tells investors in a research note. Further, he believes recent management changes and acquisitions at the company create an opportunity for outperformance. He keeps a Buy rating on Diplomat Pharmacy with a $35 price target.

TODAY'S FREE FLY STORIES

12:01
11/21/18
11/21
12:01
11/21/18
12:01
General news
EIA natural gas storage change for week ending November 16 »

Gas inventories 134 Bcf…

GS

Goldman Sachs

$193.29

1.95 (1.02%)

11:55
11/21/18
11/21
11:55
11/21/18
11:55
Periodicals
Abu Dhabi fund sues Goldman Sachs over 1MDB scandal, FT says »

Abu Dhabi's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNHBF

ICC International Cannabis

$0.00

(0.00%)

, CGC

Canopy Growth

$34.08

2.17 (6.80%)

11:51
11/21/18
11/21
11:51
11/21/18
11:51
OnTheFly
Rising High: International Cannabis agrees to acquire Green Gene »

Welcome to "Rising High,"…

KNHBF

ICC International Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$34.08

2.17 (6.80%)

MMNFF

MedMen

$0.00

(0.00%)

ACB

Aurora Cannabis

$6.27

0.23 (3.81%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$8.57

0.38 (4.64%)

CANN

General Cannabis

$0.00

(0.00%)

IGC

India Globalization Capital

$0.00

(0.00%)

TLRY

Tilray

$107.50

3.56 (3.43%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

CRM

Salesforce

$124.33

3.61 (2.99%)

11:50
11/21/18
11/21
11:50
11/21/18
11:50
Options
Put spread in Salesforce as shares bounce 3% »

Put spread in Salesforce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 06

    Dec

  • 11

    Dec

  • 03

    Mar

11:45
11/21/18
11/21
11:45
11/21/18
11:45
General news
Treasury's $11 B 10-year TIPS reopening was ok »

Treasury's $11 B…

11:45
11/21/18
11/21
11:45
11/21/18
11:45
General news
Atlanta Fed's Q4 GDPNow estimate was unchanged at 2.5% »

Atlanta Fed's Q4…

11:45
11/21/18
11/21
11:45
11/21/18
11:45
General news
Breaking General news story  »

Week of 11/16 EIA Natural…

AQST

Aquestive Therapeutics

$9.60

-3.57 (-27.11%)

, RDY

Dr. Reddy's

$36.89

0.41 (1.12%)

11:44
11/21/18
11/21
11:44
11/21/18
11:44
Recommendations
Aquestive Therapeutics, Dr. Reddy's analyst commentary  »

Aquestive selloff on…

AQST

Aquestive Therapeutics

$9.60

-3.57 (-27.11%)

RDY

Dr. Reddy's

$36.89

0.41 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

HIG

Hartford Financial

$44.70

0.6 (1.36%)

11:40
11/21/18
11/21
11:40
11/21/18
11:40
Options
Higher option volume in Hartford fueled by call buying »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

11:36
11/21/18
11/21
11:36
11/21/18
11:36
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

11:36
11/21/18
11/21
11:36
11/21/18
11:36
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

11:35
11/21/18
11/21
11:35
11/21/18
11:35
General news
Treasury announced a $111 B package of short dated coupons auctions for next week »

Treasury announced a $111…

BECN

Beacon Roofing

$32.97

4.9 (17.46%)

11:32
11/21/18
11/21
11:32
11/21/18
11:32
Upgrade
Beacon Roofing rating change  »

Beacon Roofing upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PCG

PG&E

$24.20

0.64 (2.72%)

11:30
11/21/18
11/21
11:30
11/21/18
11:30
Options
2K PG&E Mar 28 - 33 call spreads bought for $1.58 »

2K PG&E Mar 28 - 33…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:25
11/21/18
11/21
11:25
11/21/18
11:25
General news
Treasury's 10-year TIPS preview: the $11 B reopening may be weakened »

Treasury's 10-year…

AMD

AMD

$19.24

0.04 (0.21%)

11:20
11/21/18
11/21
11:20
11/21/18
11:20
Options
Sweep buyers of AMD weekly puts »

Sweep buyers of AMD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 06

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/21/18
11/21
11:17
11/21/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/21/18
11/21
11:16
11/21/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYAD

Celyad

$26.97

(0.00%)

, BLUE

Bluebird Bio

$116.82

0.55 (0.47%)

11:11
11/21/18
11/21
11:11
11/21/18
11:11
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

CYAD

Celyad

$26.97

(0.00%)

BLUE

Bluebird Bio

$116.82

0.55 (0.47%)

NVS

Novartis

$88.49

1.51 (1.74%)

GILD

Gilead

$67.04

-0.54 (-0.80%)

CELG

Celgene

$67.69

0.93 (1.39%)

AUTL

Autolus Therapeutics

$42.60

1.4 (3.40%)

ALLO

Allogene Therapeutics

$26.40

0.79 (3.08%)

CLLS

Cellectis

$20.89

0.65 (3.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 01

    Dec

  • 02

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 10

    Dec

  • 13

    Dec

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
2-Yr FRN Note Announcement CUSIP Number data reported »

2-Yr FRN Note…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
2-Yr FRN Note Announcement Offering Amount data reported »

2-Yr FRN Note…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
7-Yr Note Announcement CUSIP Number data reported »

7-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
7-Yr Note Announcement Offering Amount data reported »

7-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
5-Yr Note Announcement CUSIP Number data reported »

5-Yr Note Announcement…

11:10
11/21/18
11/21
11:10
11/21/18
11:10
General news
5-Yr Note Announcement Offering Amount data reported »

5-Yr Note Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.